SANOFI;UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.);INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
The present invention concerns a neuroglobin agonist for use in the treatment or prevention of a mitochondrial disease associated with respiratory chain complex I (RCCI) deficiency and/or respiratory chain complex III (RCCIII) deficiency.